Supernus Pharmaceuticals and Exelixis Inc. have the cash to be able to take some chances in order to improve their business prospects.
Try this options strategy on PLTR's solid earnings.
Investment experts pick their favorite stock plays for those looking to add defensive qualities to a long-term portfolio.
Ransomware attacks and other cyber threats are accelerating, which means more business for companies that fight them.
With so many questions around inflation, COVID, the Fed, and stimulus and policy, it's hard to determine what will happen in the rates market. Here's my take.
The second-quarter results of most names have exceeded estimates, but the sector faces challenges ahead due to labor shortages and rising costs.
These picks are attractive for value-oriented dividend investors looking for strong current income potential.
The tale of two rideshare earnings tapes could tip the scales of opinion.
These names have demonstrated over a long period they have the business models and growth prospects to raise their dividend payments each year.
Organon's management team has deep leadership, operating and financial experience.